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Abstract 
 Acharya Sushruta has mentioned a detail description of inflammatory swelling under 
the heading of Vranashopha. Clinical features of Vranashopha are much resembled to 
inflammatory swelling like as cellulitis. Cellulitis can cause mild discomfort to severe 
toxaemia, which can lead to death. In such condition, only systemic drugs are in clinical use, 
but they are not much helpful to eradicate the acute problem. It is probably, due to lack of 
their local availability on the swollen area, which further leads to ischemia cell death and 
ultimately gangrene formation. In this way we hypothesize that drugs, which could reduce 
local swelling/tissue damage, may be helpful in management of inflammation. Dashang lepa 
(mixture of ten indigenous drugs) mixed with 1/5
th
 part of pure cow’s ghrita (butter) was 
taken for external application over Vranashopha (cellulitis) in trial group. Clinical study in 20 
patients of cellulitis in respect of local and generalized criteria was done. In the study, group 
containing Dashang lepa showed statistically highly significant (<0.01) in terms of reduction 
of pain, edema, erythema, tenderness and fever in the patients of cellulitis. Thus results 
revealed Dashang lepa is very effective against superficial inflammatory swelling. 
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Introduction: 
           Acharya Sushruta, father of Indian 
surgery (Shalya Tantra) was well aware of 
importance of Vranashopha (inflammatory 
swelling) and Vrana (wound) and their 
management in surgical practice. The 
Vranashopha was described as earlier 
phase of Vrana (1). 
Clinical features of Vranashopha 
told by Acharya Sushruta very much 
resembles inflammatory swelling like as 
cellulitis. Cellulitis is characterised by an 
acute, diffuse, spreading, oedematous non 
suppurative inflammation of the dermis 
and subcutaneous tissues (2). Cellulitis can 
cause mild discomfort to severe 
complications like sepsis, local gangrene, 
necrotising fasciitis, septicaemia which 
can lead to death (3).
 
Condition of 
necrotising fasciitis is very dangerous 
which has 39% of mortality rate (4). So it 
is necessary to prevent spreading 
inflammation in primary condition and 
save more hazardous complications in 
health system. Though there are several 
systemic anti-microbial drugs are available 
for management of the problem but these 
are not sufficient to eradicate the acute 
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problem completely and have their own 
limitations. In that way, external (local) 
application of some herbal drug 
formulation over cellulitis can also prove 
better to manage the disease. Dashang 
lepa (mixture of ten indigenous drugs) 
mixed with 1/5
th
 part of pure cow’s ghrita 
(butter) was selected for external 
application over Vranashopha (cellulitis) 
in trial group. Ointment Su-mag (i.e. 
combination of dried magnesium sulphate 
58%, urea 1%, sulphacetamide sodium 
2.5%, proflavine and glycerine) was 
advised in control group. This clinical 
study was done in 20 patients of cellulitis 
in the Department of Shalya Tantra, 
Faculty of Ayurveda, Institute of Medical 
Sciences, Banaras Hindu University, 
Varanasi.  
 
Material and Method: 
 Dashang lepa is a powdered form 
herbal preparation made by ten indigenous 
drugs. These drugs and their properties 
with useful part are given in table no. 1 
                    
Table: 1 Contents of Dashang lepa and their Properties  
Plant 
Rasa 
(Taste) 
Guna 
(Physical 
properties
) 
Virya 
(Potency
) 
Vipaka 
(Outcom
e after 
digestion
)  
Dosh karma 
(Effect on 
doshas) 
Useful 
part 
1.Shirish 
(Albizzia 
lebbeck Benth.) 
Kashaya 
Laghu, 
Ruksha 
Ishad- 
Ushna 
Katu 
Tridoshahar
a 
Bark 
2.Madhuyasthi 
(Glycyrrhiza 
glabra Linn.) 
Madhura 
Guru, 
Snigdha 
Sheeta Madhura 
Vata-
Pittashamak 
Root 
3.Tagar     
(Valeriana 
wallichii DC.) 
Tikta,Katu
, 
Kashaya 
Laghu, 
Snigdha 
Ushna Katu 
Kapha-
Vatashamak 
Root 
4.Raktachanda
n (Pterocarpus 
santalinus 
Linn.) 
Tikta, 
Madhura 
Guru, 
Ruksha 
Sheeta Katu 
Kapha-Pitta 
shamak 
Heartwoo
d 
5.Ela (Eletteria 
cardamomum 
Linn. Maton) 
Katu, 
Madhura 
Laghu, 
Ruksha 
Sheeta Madhura 
Tridoshahar
a 
Fruit-Seed 
6.Jatamansi  
(Nardostachys 
jatamansi DC.) 
Tikta, 
Kashaya, 
Madhura 
Laghu, 
Snigdha, 
Tikshna 
Sheeta Katu 
Kapha- 
Pittashamak
, 
Rhizome 
7.Haridra  
(Curcuma 
longa Linn.) 
Tikta, 
Katu 
Laghu, 
Ruksha  
Ushna Katu 
Kapha-Vata 
shamak, 
Pittarechak 
Rhizome 
8.Daruharidra 
(Berberis 
aristata DC.) 
Tikta, 
Kashaya 
Laghu, 
Ruksha 
Ushna Katu 
Kapha-Vata 
shamak, 
Root 
Rasanjana
, 
9.Kushta 
(Saussurea 
lappa 
C.B.Clarke) 
Tikta, 
Katu 
Laghu, 
Ruksha 
Ushna Katu 
Kapha-Vata 
shamak 
Root 
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10.Hrivera 
(Pavonia 
odorata Willd.) 
Tikta,Katu
, 
Kashaya 
Laghu, 
Snigdha 
Sheeta Katu 
Kapha-
Vatashamak
a 
Root 
 
 
Dashang lepa is mentioned in 
many Ayurvedic texts (5,6,7,8,9) and 
described as Vranasophaghna (anti-
inflammatory) remedy for local 
application. Some plants of Dashang lepa 
were collected from periphery of Varanasi 
and some were obtained from local 
market. All the plants were perfectly 
identified with the help of Department of 
Dravyaguna, Faculty of Ayurveda, IMS, 
BHU. All 10 drugs were taken in equal 
amount and thoroughly washed in running 
tap water and dried in the natural shade at 
about 26°C Temperature. Completely 
dried drugs were grinded in a mixer and 
obtained powder was filtered through the 
sieve no. 85. The fine powder was kept in 
a dry and air tight container. Dashang lepa 
is mixed with Cow’s pure ghrita in 5:1 
ratio for local application.  
 After detailed clinical history and 
informed consent 24 patients with sign and 
symptom of cellulitis were registered as 
per designed proforma from the OPD/IPD 
of the Department of Shalya Tantra, Sir 
Sunderlal hospital I.M.S., B.H.U., 
Varanasi (U.P.). Random selection was 
made irrespective of age, sex, occupation, 
duration of disease, economic status etc. 
Out of these 20 patients could complete 
the study and 4 patients discontinued the 
treatment so they were not included in the 
study. Routine and needful investigation 
such as CBC, Blood sugar, RFT, LFT, 
HIV, HBsAg, had been done.  
 
Inclusion Criteria: 
 Cellulitis of all parts of body 
except orbital cellulitis, with sign and 
symptoms as pain, tenderness, edema, 
erythema, local temperature and fever 
were included.  
 
 
 
Exclusion criteria: 
Patients of Diabetes mellitus, 
Hypertension, Chronic Renal Failure, 
Malignancy, Orbital cellulitis, HBsAg 
positive, HIV positive were excluded from 
the study. 
 
Assessment Criteria for cellulitis:  
Local: Local criteria as colour (erythema), 
edema, temperature, induration, tenderness 
were assessed by different grading system 
in the patient with cellulitis. Mild, 
moderate and severe grading were done 
according to standard protocol. 
Generalised: Generalised criteria as 
general condition, pulse rate, blood 
pressure, respiration rate, pain, fever were 
assessed. 
Investigation: Investigation as TLC (Total 
Leukocyte Count), DLC (Differentiate 
Leukocyte Count), ESR (Erythrocyte 
Sedimentation Rate) were selected for 
assessment. 
 Local and generalised criteria were 
assessed daily and investigation criteria 
were assessed weekly and grading of the 
criteria was done according to designed 
proforma. 
Statistical analysis: Mean and Standard 
deviations (SD) of all variable calculated. 
Within the group paired t-test was done of 
all groups and t and p value was calculated 
(10). 
 
Plan of study: 
 Patient with sign and symptom of 
cellulitis were divided in two groups on 
basis of Total Leucocyte Count [TLC]; 
1. Group I- In this group 10 patients 
with <15,000 cells/mm
3
 TLC were 
registered. These were further divided 
in sub group: A. Control – 5 patients 
of control group were treated by local 
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application of ointment Su-mag B. 
Trial – 5 patients of trial group were 
treated by local application of 
Dashang Lepa. No antibiotic was 
given in this group.  
2. Group II- In this group 10 patients 
with >15,000 cells/mm
3
 TLC were 
registered. These were further divided 
in sub group: A. Control – 5 patients 
of control group were treated with 
Antibiotic Inj. Ceftriaxone and 
Sulbactum in dose 1.5 gm I.V. B.D. in 
adult with local application of 
ointment Su-mag. B. Trial – 5 
patients of trial group were treated 
with Antibiotic Inj. Ceftriaxone and 
Sulbactum I.V. in dose 1.5 gm I.V. 
B.D in adult with local application of 
Dashang lepa. Total duration of 
treatment were given as per require. 
But for clinical study the data were 
collected and analysed for 15 days at 
the interval of 5 days for three 
successive follow-ups. 
 
Results: 
 Out of 20 patient 70% were male 
and prevalence of cellulitis was 
found maximum 35%in age group 
between 41-50 years. Incidence of 
disease was found more in farmers. 
Maximum 50% patients were of 
Pitta dominant prakriti. Lower 
extremity was found most common 
anatomical site of cellulitis 
infection which comprised 65% of 
total patients. The outcome was 
considered as 20% patients were 
got suppuration and 80% were got 
resolution of inflammation. 
 Pain experienced by patients before 
treatment and during three 
successive follow-ups was 
estimated and paired t-test was 
applied for t and p value. The mean 
of pain before treatment was 2.80, 
3.00, 2.80, 3.00 in group IA, IB, 
IIA, IIB respectively and in third 
follow up it was 1.60, 1.00, 1.00, 
0.00 in group IA, IB, IIA, IIB 
respectively. Group IB and IIB 
were statistically highly significant 
(p<0.01) in terms of reduction of 
pain. 
 The mean of edema before 
treatment was same 3.00 in all 
groups but in third follow up (F3) it 
was 2.00, 0.60, 0.80, 0.20 in group 
IA, IB, IIA, IIB respectively. 
Group IB, IIA, IIB were 
statistically highly significant 
(p<0.001) in terms of reduction in 
edema. 
 The mean of tenderness before 
treatment was 2.6, 3.0, 2.6, 2.8 in 
group IA, IB, IIA, IIB respectively 
and in third follow up it was is 1.4, 
0.6, 1.2, 0.2 in group IA, IB, IIA, 
IIB respectively. 
 The mean of erythema before 
treatment was 2.2, 2.8, 2.4, 3.0 and 
in third follow up it was 1.6, 0.6, 
1.0, 0.2 in group IA, IB, IIA, IIB 
respectively. Group IB and IIB 
were statistically highly significant 
(p<0.001) in terms of reduction in 
erythema. 
 The mean of fever before treatment 
was 2.2, 2.8, 2.4, 2.4 and in third 
follow up it was 1.4, 0.8, 0.4, 0.0 in 
group IA, IB, IIA, IIB respectively. 
Group IA was statistically 
significant (p<0.05) and Group IB 
and II (A & B) were statistically 
highly significant (p<0.01) in terms 
of fever. 
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Table: 2 Statistical analysis of Pain before and after treatment in all groups 
  
Groups 
 
 PAIN SCORE (Mean ± SD ) Within the 
group 
comparison 
paired t-test  
(BT-F3) 
Before     
Treatment 
(BT) 
After Treatment(AT) 
F1 F2 F3 
 
 
 
I 
 
A 
2.80 ± 0.45 
 
2.40 ± 0.55 2.00 ± 0.00 1.60 ± 0.55 1.20 ± 0.45   
t=6.00      
p<0.01(HS)     
B 
 3.00 ± 0.00 2.00 ± 0.71 1.40 ± 0.55 1.00 ± 0.71 2.00 ± 0.71 
t=6.32    
p<0.01(HS) 
 
 
 
II 
A 
 2.80 ± 0.45 2.40 ± 0.55 1.80 ± 0.45 1.00 ± 0.71 1.80 ± 0.84 
t=4.81    
p<0.01(HS) 
B 
 3.00 ± 0.00 1.60 ± 0.54 0.80 ± 0.45 0.00 ± 0.00 -- 
 
(SD- Standard Deviation, F1- First follow up, F2- Second follow up, F3- Third follow up, 
HS-Highly Significant)    
 
 
 
Table: 3 Statistical analysis of Edema before and after treatment in all groups 
  
 
Group 
      EDEMA SCORE (Mean ± SD ) Within the group 
comparison 
paired t-test  (BT-
F3) 
Before     
Treatment 
(BT) 
After Treatment(AT) 
F1 F2 F3 
 
 
 I 
 
A 
3.00 ± 0.00 
 
2.40 ± 0.55 2.20 ± 0.45 2.00 ± 0.71 1.00 ± 0.71   
t=3.16      
p<0.05(S)     
B 
 3.00 ± 0.00 1.40 ± 0.55 1.00 ± 0.71 0.60 ± 0.55 2.40 ± 0.55 
t=9.79    
p<0.001(HS) 
 
 
II 
A 
 3.00 ± 0.00 2.00 ± 0.71 1.40 ± 0.55 0.80 ± 0.84 2.20 ± 0.84 
t=5.88    
p<0.01(HS) 
B 
 3.00 ± 0.00 1.20 ± 0.45 0.60 ± 0.55 0.20 ± 0.45 2.80 ± 0.45 
t=14.00    
p<0.001(HS) 
(S- Significant) 
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Table: 4 Statistical analysis of Tenderness before and after treatment 
TENDERNESS  SCORE (Mean ± SD) 
 
Group 
Before     
Treatment 
(BT) 
After Treatment(AT) 
Within the 
group 
comparison 
paired t-test  
(BT-F3) 
F1 F2 F3 
 
 
I 
 
A 
2.60 ± 0.89 
 
2.00 ± 0.71 1.60 ± 0.89 1.40 ± 0.89 1.20 ± 0.45   
t=6.00      
p<0.01(HS)     
B 
 3.00 ± 0.00 1.60 ± 0.55 0.80 ± 0.45 0.60 ± 0.55 2.40 ± 0.55 
t=9.80    
p<0.001(HS) 
 
 
II 
A 
 2.60 ± 0.55 2.00 ± 0.00 1.80 ± 0.45 1.20 ± 0.45 1.40 ± 0.55 
t=5.72    
p<0.01(HS) 
B 
 2.80 ± 0.45 1.40 ± 0.55 0.60 ± 0.55 0.20 ± 0.45 2.60 ± 0.55 
t=10.61    
p<0.001(HS) 
 
 
                 
Table: 5 Statistical analysis of Erythema before and after treatment 
ERYTHEMA  SCORE (Mean ± SD) 
 
Groups   
Before     
Treatment 
(BT) 
After Treatment(AT) 
Within the 
group 
comparison 
paired t-test  
(BT-F3) 
F1 F2 F3 
 
 
I 
 
A 
2.20 ± 0.84 
 
2.00 ± 0.71 1.80 ± 0.45 1.60 ± 0.55 0.60 ± 0.54   
t=2.45      
p>0.05(NS)     
B 
 2.80 ± 0.45 1.20 ± 0.45 1.20 ± 0.45 0.60 ± 0.55 2.20 ± 0.45 
t=11.00    
p<0.001(HS) 
 
 
II 
A 
 2.40 ± 0.55 2.20 ± 0.45 1.60 ± 0.55 1.00 ± 1.00 1.40 ± 0.89 
t=3.50   
p<0.05(S) 
B 
 3.00 ± 0.00 1.20 ± 0.83 0.60 ± 0.55 0.20 ± 0.45 2.80 ± 0.45 
t=14.00    
p<0.001(HS) 
 (NS- Not Significant) 
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      Table: 6 Statistical analysis of Fever before and after treatment in all groups 
FEVER  SCORE (Mean ± SD) 
 
Groups 
Before     
Treatment 
(BT) 
After Treatment(AT) 
Within the 
group 
comparison 
paired t-test  
(BT-F3) 
F1 F2 F3 
 
 
 I 
 
A 
2.20 ± 0.84 
 
2.00 ± 0.71 1.60 ± 0.55 1.40 ± 0.55 0.80 ± 0.45   
t=4.00      
p<0.05(S)     
B 
 2.80 ± 0.45 1.20 ± 0.45 1.00 ± 0.00 0.80 ± 0.45 -- 
 
 
II 
A 
 2.40 ± 0.55 1.40 ± 0.89 1.20 ± 0.84 0.40 ± 0.55 2.00 ± 0.70 
t=6.32   
p<0.01(HS) 
B 
 2.40 ± 0.89 1.00 ± 0.71 0.40 ± 0.55 0.00 ± 0.00 2.40 ± 0.89 
t=6.00    
p<0.01(HS) 
 
               Total relief in Sign and Symptoms of Cellulitis during treatment  
         Table: 7 Relief percentages on the signs and symptoms of Cellulitis (n = 20) 
Sr. 
No 
Symptoms Groups Symptom Score % Decrease in 
symptom score 
after treatment 
B T AT DIFF. 
1. Pain IA 14 8 6 42.85 
IB 15 4 11 73.33 
 IIA 14 5 9 64.28 
IIB 15 0 15 100 
2. Edema IA 15 10 5 33.33 
IB 15 3 12 80.00 
 IIA 15 4 11 73.33 
IIB 15 1 14 93.33 
3. Tenderness IA 13 7 6 46.15 
IB 15 3 12 80.00 
 IIA 13 6 7 53.84 
IIB 14 1 13 92.85 
4. Erythema IA 11 8 3 27.27 
IB 14 3 11 78.57 
 IIA 12 5 7 58.33 
IIB 15 1 14 93.33 
5. Fever  IA 11 7 4 36.36 
IB 14 4 10 71.42 
 IIA 12 2 10 83.33 
IIB 12 0 12 100 
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Fig: 1 Total relief in sign and symptoms of cellulitis during treatment with all groups      
CASE: 1: 
 
Left leg cellulitis before treatment 
(Day-0) 
 
During application of Dashang lepa 
 CASE: 2 : 
 
Scrotum cellulitis before treatment 
(Day-0) 
 
During application of Dashang lepa 
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After application of Dashang lepa 
(Day-5) 
 
After application of Dashang lepa 
(Day-5)  
 
     
Fig. 2 Application of Dashang Lepa in patients of Cellulitis 
 
 
Discussion: 
 The present study revealed that the 
Dashang lepa is very effective and 
statistically highly significant (p<0.01) in 
terms of pain. It might be due to decrease 
in prostaglandin level. This clearly shows 
this drug contain analgesic properties. 
Inflammatory edema is reduced which is 
probably due to Dhatushoshak 
(absorptive) effect of Kashaya and Tikta 
Rasa (taste) of most of the drugs in 
Dashang lepa. It alleviates vitiated Kapha 
to reduce the edema. Erythema in 
inflammatory process is due to increase 
blood supply over injured area due to 
vasodilation. In present study Dashang 
lepa has shown statistically highly 
significant (p<0.001) in terms of reduction 
in erythema (redness). This might be due 
to Pittashamak effect of the drug when 
apply with cow’s pure butter (ghrita). The 
Kashaya, Tikta rasa and Sheeta Virya have 
capability to constrict blood vessels, hence 
it reduces the erythema.                                                                        
Most of the patient showed significant 
relief and found to be free from toxic 
effect of disease within 2-3 days of the 
application of Dashang Lepa. This is 
probably due to it makes a barrier to 
superficial of the diseased region when 
applied with ghrita so can also prevent 
further invasion of bacteria.  
 
Conclusion: 
  Dashang lepa reduces all cardinal 
features of inflammation as Pain (Dolor), 
Edema (Tumour), Erythema (Rubor), 
Tempreture (Calor) in patients of cellulitis. 
Thus it can be proven as potent anti-
inflammatory medicine. In present study 
Dashang lepa was taken with ghrita in 5:1 
ratio to form paste and applied lukewarm 
on affected area according to mentioned in 
Ayurvedic literature. No adverse reaction 
was found after topical application of 
Dashang lepa; hence it is proven safe and 
to be applying in each age group of 
patients. It is a preliminary study on 
Dashang lepa and further research works 
are going on in experimental model. 
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